Drugdiscovery >> Drugs >> News
4046
Views
Orlistat might cause kidney stones - drugdiscovery.com
Orlistat might cause kidney stones - drugdiscovery.com


The results of an animal study suggest that one of the side effects of an anti-obesity drug orlistat might be the increased risk of kidney stones.
Read More >>


Tags: orlistat, anti-obesity drug, risk, side effects, kidney stones, animal study - August 12, 2013
Related Articles
3729
Views
No recommendation for tolvaptan for treatment of ADPKD in US No recommendation for tolvaptan for treatment of ADPKD in US
The FDA’s advisory committee decided not to recommend Otsuka’s drug tolvaptan for the indication of slowing kidney disease in adults at risk for rapidly progressing autosomal dominant polycystic Read More >>

Tags: Otsuka,tolvaptan, kidney disease, rapidly progressing autosomal dominant polycystic kidney disease, kidney, polycystic

6597
Views
Zerenex, a promising drug for treating chronic kidney disease Zerenex, a promising drug for treating chronic kidney disease
Keryx Biopharmaceuticals has submitted a New Drug Application to the FDA. The drug is iron-based phosphate binder Zerenex, which showed impressive results in a phase III trial in treating elevated s Read More >>

Tags: Keryx Biopharmaceuticals, Zerenex, chronic kidney disease

4337
Views
Triferic - a trade name of Rockwell Medical's chronic kidney disease drug Triferic - a trade name of Rockwell Medical's chronic kidney disease drug
The FDA has accepted the proposed proprietary trade name for the Rockwell Medical's soluble ferric pyrophosphate (SFP), an investigational iron-delivery drug intended for treating iron deficiency in Read More >>

Tags: Triferic, chronic kidney disease, iron deficiency, new drug, Rockwell Medical, soluble ferric pyrophosphate

1221
Views
ASTAGRAF XL now available in U.S. pharmacies ASTAGRAF XL now available in U.S. pharmacies
Astelas’ ASTAGRAF XL, a once-daily oral tacrolimus formulation for the prophylaxis of organ rejection in adult kidney transplant patients is now available in the U.S. Read More >>

Tags: astagraf xl, astellas, prophylaxis, organ rejection, kidney, transplant

2878
Views
New diabetes drug, Forxiga was apporved by FDA New diabetes drug, Forxiga was apporved by FDA
Astra Zeneca's new anti-diabetes drug, Forxiga was approved by US Food and Durg Administration. This is a sodium-glucose co-transporter, which blocks the reabsorption of glucose by the kidney. Read More >>

Tags: kidney, reabsortion, glucose, Forxiga, AstraZeneca

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013